Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.93
+0.57 (7.74%)
At close: Aug 7, 2026, 4:00 PM EDT
7.95
+0.02 (0.25%)
Pre-market: Aug 10, 2026, 7:45 AM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.45 billion as of August 10, 2026. Its market cap has increased by 64.44% in one year.
Market Cap
1.45B
Enterprise Value
1.61B
1-Year Change
64.44%
Ranking
Category
Stock Price
$7.93
ChartMarket Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.45B, an increase of 388.81%. That is a compound annual growth rate of 38.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 1.45B | 11.00% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 2.16B |
| Perrigo Company | 1.78B |
| Trulieve Cannabis | 1.68B |
| ANI Pharmaceuticals | 1.68B |
| Harrow | 1.51B |
| Phibro Animal Health | 1.39B |
| Alvotech | 1.36B |
| Eton Pharmaceuticals | 1.22B |